Literature DB >> 17379249

Simple scaling laws for influenza A rise time, duration, and severity.

David B Chang1, Carl S Young.   

Abstract

Simple scaling laws are developed for the severity and characteristic time scales of influenza A infection in man. The scaling laws are based on a model of the infection described by six coupled ordinary differential equations that describe the time courses of the numbers of infectious viral particles, activated cytotoxic T-lymphocytes, interferon molecules, infected cells, uninfected cells, and the subset of uninfected cells that are protected by interferon from viral infection. Computer simulations show that the disease can be regarded approximately as a two-stage process. In the first stage, the growth in the number of infected cells is determined primarily by the interferon-enhanced limitation in the available number of target cells. In the second stage, the bulk of the duration of the infection is determined mainly by the destruction of the infected cells by the cytotoxic T-lymphocytes. The severity and characteristic times of the infection are found to depend simply on the logarithm of the initial number of viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379249     DOI: 10.1016/j.jtbi.2007.02.004

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  10 in total

Review 1.  Influenza A virus infection kinetics: quantitative data and models.

Authors:  Amber M Smith; Alan S Perelson
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

2.  Agent-based modeling of host-pathogen systems: The successes and challenges.

Authors:  Amy L Bauer; Catherine A A Beauchemin; Alan S Perelson
Journal:  Inf Sci (N Y)       Date:  2009-04-29       Impact factor: 6.795

3.  DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis.

Authors:  Gallen B Triana-Baltzer; Maria Babizki; Michael C W Chan; Adam C N Wong; Laura M Aschenbrenner; Erin R Campbell; Qi-Xiang Li; Renee W Y Chan; J S Malik Peiris; John M Nicholls; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2009-11-26       Impact factor: 5.790

4.  Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.

Authors:  A Cristina Paulo; Margarida Correia-Neves; Tiago Domingos; Alberto G Murta; Jorge Pedrosa
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

5.  Understanding original antigenic sin in influenza with a dynamical system.

Authors:  Keyao Pan
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

6.  A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead.

Authors:  Catherine A A Beauchemin; Andreas Handel
Journal:  BMC Public Health       Date:  2011-02-25       Impact factor: 3.295

7.  Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.

Authors:  Pengxing Cao; Ada W C Yan; Jane M Heffernan; Stephen Petrie; Robert G Moss; Louise A Carolan; Teagan A Guarnaccia; Anne Kelso; Ian G Barr; Jodie McVernon; Karen L Laurie; James M McCaw
Journal:  PLoS Comput Biol       Date:  2015-08-18       Impact factor: 4.475

8.  Modelling the Innate Immune Response against Avian Influenza Virus in Chicken.

Authors:  T J Hagenaars; E A J Fischer; C A Jansen; J M J Rebel; D Spekreijse; L Vervelde; J A Backer; M C M de Jong; A P Koets
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

9.  On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection.

Authors:  Pengxing Cao; Zhongfang Wang; Ada W C Yan; Jodie McVernon; Jianqing Xu; Jane M Heffernan; Katherine Kedzierska; James M McCaw
Journal:  Front Immunol       Date:  2016-12-20       Impact factor: 7.561

10.  Assessing mathematical models of influenza infections using features of the immune response.

Authors:  Hana M Dobrovolny; Micaela B Reddy; Mohamed A Kamal; Craig R Rayner; Catherine A A Beauchemin
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.